Patent intelligence · US
US 9138451
Plant extract hydrolysates and antibacterial product containing the same
Plant extract hydrolysates and antibacterial product containing the same
Patent details — US 9138451
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 22, 2015
- Expiration
- Sep 17, 2035
- Applicant
- BIONORICA SE
- Claims
- 22
- CPC classes
- A61K, A61K36/11, A61K36/12, A61K36/185
Quick answer
US 9138451 (Plant extract hydrolysates and antibacterial product containing the same) is held by BIONORICA SE. Status: granted. Granted Sep 22, 2015. Expires Sep 17, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIONORICA SE
- Grant date
- Expiration
- Claims
- 22
- CPC classes
- A61K, A61K36/11, A61K36/12, A61K36/185, A61K36/23, A61K36/232
More from BIONORICA SE
Related pharmaceutical patents in our USPTO index.
-
US 12312339
Polo like kinase 4 inhibitors
granted -
US 12239729
TRPV3 agonists for the treatment of skin conditions
granted -
US 12054556
Anti-PD-L1 antibody and use thereof
granted -
US 12018043
CD73 inhibitors
granted -
US 12005080
Method for promoting proliferation of immune cells
granted -
US 11993655
Anti-PD-L1 antibody and use thereof
granted -
US 11858915
Polo like kinase 4 inhibitors
granted -
US 11807658
CD73 inhibitors
granted
Frequently asked questions
What is US patent 9138451?
US 9138451 (Plant extract hydrolysates and antibacterial product containing the same) is held by BIONORICA SE. Status: granted. Granted Sep 22, 2015. Expires Sep 17, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9138451?
BIONORICA SE is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 52 pharmaceutical patents for this assignee.
When does US 9138451 expire?
Our index shows an expiration date of Sep 17, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.